4//SEC Filing
BROWN MICHAEL S 4
Accession 0001968202-25-000003
CIK 0000872589other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:05 PM ET
Size
8.8 KB
Accession
0001968202-25-000003
Insider Transaction Report
Form 4
BROWN MICHAEL S
Director
Transactions
- Award
Common Stock
2025-01-02+166→ 1,548 total - Award
Non-Qualified Stock Option (right to buy)
2025-01-02+1,958→ 1,958 totalExercise: $719.37Exp: 2035-01-02→ Common Stock (1,958 underlying)
Holdings
- 6,162(indirect: By Trust)
Common Stock
- 5,000(indirect: by SLAT)
Common Stock
Footnotes (3)
- [F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
- [F2]These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001174475
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:05 PM ET
- Size
- 8.8 KB